Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    19880844 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Trial to Reduce Cardiovascular Events With Aranesp® Therapy (TREAT)
Conditions: Kidney Disease;   Diabetes Mellitus;   Anemia
Interventions: Drug: Placebo;   Drug: darbepoetin alfa

Study has passed its completion date and status has not been verified in more than two years.